Article
Molecular dynamic study on PTEN frameshift mutations in breast cancer provide c2 domain as a potential biomarker.
Journal of biomolecular structure & dynamics - 1 Apr 2022
Karn Rohit, Emerson Isaac Arnold
Abstract excerpt
PTEN is a tumour suppressor gene known for regulating apoptosis, cell growth, and many other pathways. It is one of the most frequently mutated genes comprising the phosphatase domain (PD) and C terminal domain (C2). Direct therapeutic methods are not applicable for targeting PTEN because once gets mutated, it needs restoration. For mutant detection and restoration using PTEN mRNA there is a need to explore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
